Your browser doesn't support javascript.
loading
Study Confirms Safety and Effectiveness of Intra-Articular Glucocorticoids for Painful Hip Dislocation in Children and Young Adults with Neurologic Impairment.
Benvenuto, Simone; Barbi, Egidio; Boaretto, Silvia; Landolfo, Matteo; Rispoli, Francesco; Cozzi, Giorgio; Carbone, Marco.
Affiliation
  • Benvenuto S; Department of Medicine, Surgery, and Health Sciences, University of Trieste, 34127 Trieste, Italy.
  • Barbi E; Department of Medicine, Surgery, and Health Sciences, University of Trieste, 34127 Trieste, Italy.
  • Boaretto S; Institute for Maternal and Child Health IRCCS Burlo Garofolo, 34137 Trieste, Italy.
  • Landolfo M; Department of Medicine, Surgery, and Health Sciences, University of Trieste, 34127 Trieste, Italy.
  • Rispoli F; Medical Clinic, Cattinara Hospital, Azienda Sanitaria Universitaria Giuliano Isontina, 34149 Trieste, Italy.
  • Cozzi G; Department of Medicine, Surgery, and Health Sciences, University of Trieste, 34127 Trieste, Italy.
  • Carbone M; Institute for Maternal and Child Health IRCCS Burlo Garofolo, 34137 Trieste, Italy.
Children (Basel) ; 10(8)2023 Aug 06.
Article in En | MEDLINE | ID: mdl-37628352
ABSTRACT

BACKGROUND:

Hip dislocation is a common source of pain in children with neurologic impairment. When medical interventions fail, orthopedic surgery does not guarantee a definitive result as the displacement may continue postoperatively and a second operation is often required.

METHODS:

Retrospective analysis of data regarding the safety and effectiveness of an intra-articular corticosteroid injection (IACI) in 11 patients, aged 15 ± 5 years old, collected through a telephonic questionnaire administered to parents.

RESULTS:

21 IACIs were performed, a mean number of 1.9 ± 1.5 times for each patient, at a mean age (of the first IACI) of 13.5 ± 5 years. According to the parents, the IACI significantly lowered the number of participants experiencing pain (82% reduction) and using analgesics (60% reduction). There was also a significant improvement in the children's hip mobility (63% reduction in patients experiencing stiffness), decubitus (90% reduction in obligated positioning), behavior (80% reduction in lamenting or crying patients), sleep quality (87.5% reduction in patients awakening every night), and caregivers' quality of life (91% reduction in worried parents). The mean reported duration of the IACIs' benefit was 5.4 ± 2.4 months (range 1-9), with a positive correlation with the number of IACIs (r = 0.48; p-value = 0.04) and a negative correlation with the age at the first injection (r = -0.71; p-value = 0.02). The only reported adverse event was mild local swelling in one child.

CONCLUSIONS:

the IACI could represent a safe and effective intervention for painful hip dislocation, both before and after surgery, with a long-lasting benefit which seems to increase as multiple IACIs are performed.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: Children (Basel) Year: 2023 Document type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: Children (Basel) Year: 2023 Document type: Article Affiliation country: Italy